Table 15

PB and BM findings and cytogenetics of MDS

NameDysplastic lineagesCytopenias*Ring sideroblasts as % of marrow erythroid elementsBM and PB blastsCytogenetics by conventional karyotype analysis
MDS with single lineage dysplasia (MDS-SLD) 1 or 2 <15%/<5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
MDS with multilineage dysplasia (MDS-MLD) 2 or 3 1-3 <15%/<5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
MDS with ring sideroblasts (MDS-RS)      
 MDS-RS with single lineage dysplasia (MDS-RS-SLD) 1 or 2 ≥15%/≥5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
 MDS-RS with multilineage dysplasia (MDS-RS-MLD) 2 or 3 1-3 ≥15%/≥5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
MDS with isolated del(5q) 1-3 1-2 None or any BM <5%, PB <1%, no Auer rods del(5q) alone or with 1 additional abnormality except −7 or del(7q) 
MDS with excess blasts (MDS-EB)      
 MDS-EB-1 0-3 1-3 None or any BM 5%-9% or PB 2%-4%, no Auer rods Any 
 MDS-EB-2 0-3 1-3 None or any BM 10%-19% or PB 5%-19% or Auer rods Any 
MDS, unclassifiable (MDS-U)      
 with 1% blood blasts 1-3 1-3 None or any BM <5%, PB = 1%, no Auer rods Any 
 with single lineage dysplasia and pancytopenia None or any BM <5%, PB <1%, no Auer rods Any 
 based on defining cytogenetic abnormality 1-3 <15%§ BM <5%, PB <1%, no Auer rods MDS-defining abnormality 
Refractory cytopenia of childhood 1-3 1-3 None BM <5%, PB <2% Any 
NameDysplastic lineagesCytopenias*Ring sideroblasts as % of marrow erythroid elementsBM and PB blastsCytogenetics by conventional karyotype analysis
MDS with single lineage dysplasia (MDS-SLD) 1 or 2 <15%/<5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
MDS with multilineage dysplasia (MDS-MLD) 2 or 3 1-3 <15%/<5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
MDS with ring sideroblasts (MDS-RS)      
 MDS-RS with single lineage dysplasia (MDS-RS-SLD) 1 or 2 ≥15%/≥5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
 MDS-RS with multilineage dysplasia (MDS-RS-MLD) 2 or 3 1-3 ≥15%/≥5% BM <5%, PB <1%, no Auer rods Any, unless fulfills all criteria for MDS with isolated del(5q) 
MDS with isolated del(5q) 1-3 1-2 None or any BM <5%, PB <1%, no Auer rods del(5q) alone or with 1 additional abnormality except −7 or del(7q) 
MDS with excess blasts (MDS-EB)      
 MDS-EB-1 0-3 1-3 None or any BM 5%-9% or PB 2%-4%, no Auer rods Any 
 MDS-EB-2 0-3 1-3 None or any BM 10%-19% or PB 5%-19% or Auer rods Any 
MDS, unclassifiable (MDS-U)      
 with 1% blood blasts 1-3 1-3 None or any BM <5%, PB = 1%, no Auer rods Any 
 with single lineage dysplasia and pancytopenia None or any BM <5%, PB <1%, no Auer rods Any 
 based on defining cytogenetic abnormality 1-3 <15%§ BM <5%, PB <1%, no Auer rods MDS-defining abnormality 
Refractory cytopenia of childhood 1-3 1-3 None BM <5%, PB <2% Any 
*

Cytopenias defined as: hemoglobin, <10 g/dL; platelet count, <100 × 109/L; and absolute neutrophil count, <1.8 × 109/L. Rarely, MDS may present with mild anemia or thrombocytopenia above these levels. PB monocytes must be <1 × 109/L

If SF3B1 mutation is present.

One percent PB blasts must be recorded on at least 2 separate occasions.

§

Cases with ≥15% ring sideroblasts by definition have significant erythroid dysplasia, and are classified as MDS-RS-SLD.

or Create an Account

Close Modal
Close Modal